DK225579A - Imidazo (2,1-b)-(1,3,4)-thiadiazoler deres fremstilling og anvendelse - Google Patents

Imidazo (2,1-b)-(1,3,4)-thiadiazoler deres fremstilling og anvendelse

Info

Publication number
DK225579A
DK225579A DK225579A DK225579A DK225579A DK 225579 A DK225579 A DK 225579A DK 225579 A DK225579 A DK 225579A DK 225579 A DK225579 A DK 225579A DK 225579 A DK225579 A DK 225579A
Authority
DK
Denmark
Prior art keywords
imidazo
thiadiazoles
preparation
compounds
agents
Prior art date
Application number
DK225579A
Other languages
Danish (da)
English (en)
Inventor
H Horstmann
I H F Meng
M Meng
F Seuter
E Moeller
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK225579A publication Critical patent/DK225579A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Lubricants (AREA)
  • Detergent Compositions (AREA)
DK225579A 1978-05-31 1979-05-30 Imidazo (2,1-b)-(1,3,4)-thiadiazoler deres fremstilling og anvendelse DK225579A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782823686 DE2823686A1 (de) 1978-05-31 1978-05-31 Imidazo eckige klammer auf 2.1-b eckige klammer zu eckige klammer auf 1.3.4 eckige klammer zu -thiadiazole

Publications (1)

Publication Number Publication Date
DK225579A true DK225579A (da) 1979-12-01

Family

ID=6040588

Family Applications (1)

Application Number Title Priority Date Filing Date
DK225579A DK225579A (da) 1978-05-31 1979-05-30 Imidazo (2,1-b)-(1,3,4)-thiadiazoler deres fremstilling og anvendelse

Country Status (12)

Country Link
US (1) US4265898A (fr)
EP (1) EP0005783B1 (fr)
JP (1) JPS54157564A (fr)
AT (1) ATE512T1 (fr)
AU (1) AU523229B2 (fr)
CA (1) CA1128941A (fr)
DE (2) DE2823686A1 (fr)
DK (1) DK225579A (fr)
ES (1) ES481155A1 (fr)
FI (1) FI66390C (fr)
HU (1) HU179411B (fr)
IL (1) IL57420A (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444770A (en) * 1980-05-29 1984-04-24 Bayer Aktiengesellschaft New imidazoazole-alkenoic acid amide compounds, intermediate products for their production, their production, and their medicinal use
IT8148047A0 (it) * 1981-03-18 1981-03-18 Manetti & Roberts Italo Brit Composti organici derivati da 2-ami no-5-(o-solfamidofenil)-1,3,4-tiadiazolo loro applicazione terapeutica e procedimento per la loro preparazione
DE3208437A1 (de) * 1982-03-09 1983-09-15 Bayer Ag, 5090 Leverkusen Imidazothiadiazolalkencarbonsaeureamide, neue zwischenprodukte zu ihrer herstellung, ihre herstellung und ihre verwendung in arzneimitteln
US4968494A (en) * 1987-03-27 1990-11-06 Merck & Co., Inc. Methods and compositions for thrombolytic therapy
US5077285A (en) * 1989-07-31 1991-12-31 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
US5047416A (en) * 1989-07-31 1991-09-10 Merck & Co., Inc. Triazole compounds and their use as transglutaminase inhibitors
US5030644A (en) * 1989-07-31 1991-07-09 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
US5019572A (en) * 1990-02-07 1991-05-28 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
US4968713A (en) * 1989-07-31 1990-11-06 Merck & Co., Inc. Certain imidazole compounds as transglutaminase inhibitors
US5021440A (en) * 1989-07-31 1991-06-04 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
WO2008057601A2 (fr) 2006-11-08 2008-05-15 The Rockefeller University Composés organiques
CA2805724A1 (fr) 2010-07-16 2012-01-19 Rockefeller University Oxadiazolo[3,2-a]pyrimidines et thiadiazolo[3,2-a]pyrimidines
EP2804610B1 (fr) 2012-01-16 2018-10-31 The Rockefeller University Composés organiques
SI2841437T1 (sl) * 2012-04-26 2017-09-29 Bristol-Myers Squibb Company Derivati imidazotiadiazola in imidazopirazina kot proteazno aktivirani receptor 4 (PAR4) inhibitorji za zdravljenje agregacije trombocitov
EP2855489B1 (fr) * 2012-04-26 2017-01-04 Bristol-Myers Squibb Company Dérivés d'imidazothiadiazole et d'imidazopyridazine utiles comme inhibiteurs des récepteurs 4 activés par les protéases (par4) pour traiter l'agrégation plaquettaire
SG11201406759YA (en) * 2012-04-26 2014-11-27 Bristol Myers Squibb Co Imidazothiadiazole derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
EP2682395A1 (fr) * 2012-07-04 2014-01-08 Laboratorios Del. Dr. Esteve, S.A. Dérivés d'imidazo[2,1-b]thiazole, leur préparation et leur utilisation comme médicaments
US9617279B1 (en) 2014-06-24 2017-04-11 Bristol-Myers Squibb Company Imidazooxadiazole compounds
US9598419B1 (en) 2014-06-24 2017-03-21 Universite De Montreal Imidazotriazine and imidazodiazine compounds
WO2017184520A1 (fr) * 2016-04-18 2017-10-26 Vanderbilt University Antagonistes du récepteur 4 activé par une protéase à 6 éléments fusionnés et substitués (par-4)
WO2019218956A1 (fr) * 2018-05-16 2019-11-21 深圳信立泰药业股份有限公司 Composé agissant comme inhibiteur du récepteur 4 activé par la protéase (par4) pour le traitement de l'agrégation plaquettaire
CN112074522B (zh) * 2018-05-16 2022-08-26 深圳信立泰药业股份有限公司 作为用于治疗血小板聚集的蛋白酶激活受体4(par4)抑制剂的化合物
US11684622B2 (en) 2018-06-19 2023-06-27 Celecor Therapeutics, Inc. Deuterated RUC-4
WO2023093700A1 (fr) * 2021-11-29 2023-06-01 中国海洋大学 Dérivé d'imidazothiazole, son procédé de préparation et son utilisation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3726891A (en) * 1970-12-02 1973-04-10 Shell Oil Co Fused 1,2,4-thiadiazolines
US3804823A (en) * 1972-02-15 1974-04-16 Eastman Kodak Co Heterocyclic containing monoazo compounds
GB1464259A (en) * 1975-10-03 1977-02-09 Pfizer Ltd Imidazo-thiazole and -thiadiazole sulphonamides and their use as therapeutic agents
US4042372A (en) * 1976-11-19 1977-08-16 Eli Lilly And Company Substituted thiadiazolotriazinediones and method of preparation

Also Published As

Publication number Publication date
US4265898A (en) 1981-05-05
DE2961667D1 (en) 1982-02-18
IL57420A0 (en) 1979-09-30
EP0005783A1 (fr) 1979-12-12
FI66390B (fi) 1984-06-29
HU179411B (en) 1982-10-28
AU4760679A (en) 1979-12-06
AU523229B2 (en) 1982-07-15
ES481155A1 (es) 1979-11-16
IL57420A (en) 1983-06-15
JPS54157564A (en) 1979-12-12
ATE512T1 (de) 1982-01-15
DE2823686A1 (de) 1979-12-06
CA1128941A (fr) 1982-08-03
EP0005783B1 (fr) 1981-12-30
FI791708A7 (fi) 1979-12-01
FI66390C (fi) 1984-10-10

Similar Documents

Publication Publication Date Title
DK225579A (da) Imidazo (2,1-b)-(1,3,4)-thiadiazoler deres fremstilling og anvendelse
DK173883D0 (da) Substituerede 8-phenylxanthiner
NO831084L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kvartaere dibenzotiepin-n-alkyl-norskopinetere
JPS5573662A (en) Novel hydroxyethyllazole compound*its manufacture and its use as medicine
EP0002916A3 (en) The use of milbemycin compounds as anthelmintic agents and anthelmintic compositions containing such compounds
JPS55108860A (en) Hydroxypropylltriazole*its manufacture and use as medicine
IL64292A0 (en) D-homosteroids,their manufacture and pharmaceutical compositions containing them
IL58299A (en) Fluorine-containing 1,4-dihydropyridine derivatives,their production and their medicinal use
FI813912L (fi) I laekemedel anvaendbara tricykliska cytosinderivat och foerfarande foer deras framstaellning
NO822751L (no) Fremgangsmaate ved fremstilling av svovelsubstituerte fenoxypyridiner.
DK260180A (da) Pseudotrisaccharider deres fremstilling og anvendelse som antibakterielle midler
MX6274E (es) Procedimiento para la preparacion de composiciones parmaceuticas que contienen alcohilantes citostaticos destoxificados
JPS5573661A (en) Fluorenyllazolylmethyllcarbinol compound* its manufacture and its use as drug
FR2445838A1 (fr) Nouveaux 1a,3b-dihydroxy-5-steroides
DE3167565D1 (de) Anthelmintic imidazo(2,1-b)thiazole gel compositions
DK239084A (da) 2-alkylthio-1-aminoalkyl-2-pyrrolin-3-carbonitriler